Efficacy of Lenalidomide and Bortezomib for Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing after Allogeneic Stem Cell Transplantation von Brunner, Andrew M., Blonquist, Traci M., McMasters, Malgorzata, Hobbs, Gabriela S., McAfee, Steven L, Rosenblatt, Jacalyn, Amrein, Philip C., Connolly, Christine, Ramos, Aura Y., Mikami, Kaleb, Logan, Emma, Dey, Bimalangshu R, Spitzer, Thomas, Avigan, David E., Chen, Yi-Bin, Ballen, Karen K., El-Jawahri, Areej, Fathi, Amir T.

Volltext

Phase I Study of Bortezomib Combined with Lenalidomide for Relapsed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Following Hematopoietic Cell Transplantation von Brunner, Andrew M., Blonquist, Traci M., McMasters, Malgorzata, Hobbs, Gabriela S., McAfee, Steven L, Rosenblatt, Jacalyn, Amrein, Philip C., El-Jawahri, Areej, Connolly, Christine, Ramos, Aura, Mikami, Kaleb, Logan, Emma, Dey, Bimalangshu R, Spitzer, Thomas, Avigan, David E., Fathi, Amir T., Chen, Yi-Bin, Ballen, Karen

Volltext

Phase I/Ib Trial of the MUC1 Inhibitor GO-203-2C Alone and in Combination with Decitabine for Acute Myeloid Leukemia von Liegel, Jessica, Rosenblatt, Jacalyn, Stone, Richard M., McMasters, Malgorzata, Levine, James D., Nahas, Myrna, Joyce, Robin M., Jain, Salvia, DeAngelo, Daniel J., Garcia, Jacqueline S., Bazemore, Josie, Galinsky, Ilene, Neuberg, Donna S., Werner, Lillian, Logan, Emma, Mikami, Kaleb, Bryant, Mary Paty, Allen, Victoria, Stroopinsky, Dina, Cole, Leandra, Washington, Abigail J., Ephraim, Adam, Avigan, David E.

Volltext